664 related articles for article (PubMed ID: 15199122)
1. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression.
Yokoyama A; Wang Z; Wysocka J; Sanyal M; Aufiero DJ; Kitabayashi I; Herr W; Cleary ML
Mol Cell Biol; 2004 Jul; 24(13):5639-49. PubMed ID: 15199122
[TBL] [Abstract][Full Text] [Related]
2. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
[TBL] [Abstract][Full Text] [Related]
3. Menin critically links MLL proteins with LEDGF on cancer-associated target genes.
Yokoyama A; Cleary ML
Cancer Cell; 2008 Jul; 14(1):36-46. PubMed ID: 18598942
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of transformation by MLL.
Hess JL
Crit Rev Eukaryot Gene Expr; 2004; 14(4):235-54. PubMed ID: 15663355
[TBL] [Abstract][Full Text] [Related]
5. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D; Hua X; Roeder RG; Meyerson M; Hess JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):749-54. PubMed ID: 15640349
[TBL] [Abstract][Full Text] [Related]
6. Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties.
Yokoyama A; Kitabayashi I; Ayton PM; Cleary ML; Ohki M
Blood; 2002 Nov; 100(10):3710-8. PubMed ID: 12393701
[TBL] [Abstract][Full Text] [Related]
7. Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.
Hughes CM; Rozenblatt-Rosen O; Milne TA; Copeland TD; Levine SS; Lee JC; Hayes DN; Shanmugam KS; Bhattacharjee A; Biondi CA; Kay GF; Hayward NK; Hess JL; Meyerson M
Mol Cell; 2004 Feb; 13(4):587-97. PubMed ID: 14992727
[TBL] [Abstract][Full Text] [Related]
8. MLL targets SET domain methyltransferase activity to Hox gene promoters.
Milne TA; Briggs SD; Brock HW; Martin ME; Gibbs D; Allis CD; Hess JL
Mol Cell; 2002 Nov; 10(5):1107-17. PubMed ID: 12453418
[TBL] [Abstract][Full Text] [Related]
9. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development.
Hanson RD; Hess JL; Yu BD; Ernst P; van Lohuizen M; Berns A; van der Lugt NM; Shashikant CS; Ruddle FH; Seto M; Korsmeyer SJ
Proc Natl Acad Sci U S A; 1999 Dec; 96(25):14372-7. PubMed ID: 10588712
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.
Scacheri PC; Davis S; Odom DT; Crawford GE; Perkins S; Halawi MJ; Agarwal SK; Marx SJ; Spiegel AM; Meltzer PS; Collins FS
PLoS Genet; 2006 Apr; 2(4):e51. PubMed ID: 16604156
[TBL] [Abstract][Full Text] [Related]
11. MLL: a histone methyltransferase disrupted in leukemia.
Hess JL
Trends Mol Med; 2004 Oct; 10(10):500-7. PubMed ID: 15464450
[TBL] [Abstract][Full Text] [Related]
12. Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias.
So CW; Lin M; Ayton PM; Chen EH; Cleary ML
Cancer Cell; 2003 Aug; 4(2):99-110. PubMed ID: 12957285
[TBL] [Abstract][Full Text] [Related]
13. A MENage à Trois in leukemia.
Roudaia L; Speck NA
Cancer Cell; 2008 Jul; 14(1):3-5. PubMed ID: 18598937
[TBL] [Abstract][Full Text] [Related]
14. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation.
Ferrando AA; Armstrong SA; Neuberg DS; Sallan SE; Silverman LB; Korsmeyer SJ; Look AT
Blood; 2003 Jul; 102(1):262-8. PubMed ID: 12637319
[TBL] [Abstract][Full Text] [Related]
15. Interaction of MLL amino terminal sequences with menin is required for transformation.
Caslini C; Yang Z; El-Osta M; Milne TA; Slany RK; Hess JL
Cancer Res; 2007 Aug; 67(15):7275-83. PubMed ID: 17671196
[TBL] [Abstract][Full Text] [Related]
16. The role of menin in hematopoiesis.
Maillard I; Hess JL
Adv Exp Med Biol; 2009; 668():51-7. PubMed ID: 20175452
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the mixed lineage leukemia-menin interaction: implications for targeting mixed lineage leukemias.
Grembecka J; Belcher AM; Hartley T; Cierpicki T
J Biol Chem; 2010 Dec; 285(52):40690-8. PubMed ID: 20961854
[TBL] [Abstract][Full Text] [Related]
18. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1.
Kawagoe H; Kawagoe R; Sano K
Leukemia; 2001 Nov; 15(11):1743-9. PubMed ID: 11681416
[TBL] [Abstract][Full Text] [Related]
19. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.
Jin S; Zhao H; Yi Y; Nakata Y; Kalota A; Gewirtz AM
J Clin Invest; 2010 Feb; 120(2):593-606. PubMed ID: 20093773
[TBL] [Abstract][Full Text] [Related]
20. Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner.
Nie Z; Yan Z; Chen EH; Sechi S; Ling C; Zhou S; Xue Y; Yang D; Murray D; Kanakubo E; Cleary ML; Wang W
Mol Cell Biol; 2003 Apr; 23(8):2942-52. PubMed ID: 12665591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
